Fidelity Investments’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-117,483
Closed -$1.8M 2737
2017
Q3
$1.8M Sell
117,483
-52,560
-31% -$850K ﹤0.01% 2343
2017
Q2
$3.41M Sell
170,043
-3,719
-2% -$45.9K ﹤0.01% 2244
2017
Q1
$1.74M Sell
173,762
-1
-0% -$11 ﹤0.01% 2373
2016
Q4
$1.64M Hold
173,763
﹤0.01% 2402
2016
Q3
$1.88M Hold
173,763
﹤0.01% 2378
2016
Q2
$3M Sell
173,763
-18,576
-10% -$579K ﹤0.01% 2284
2016
Q1
$7.21M Sell
192,339
-48,090
-20% -$1.92M ﹤0.01% 2058
2015
Q4
$16.4M Hold
240,429
﹤0.01% 1774
2015
Q3
$13.9M Hold
240,429
﹤0.01% 1813
2015
Q2
$19M Hold
240,429
﹤0.01% 1748
2015
Q1
$16.3M Hold
240,429
﹤0.01% 1812
2014
Q4
$9.23M Hold
240,429
﹤0.01% 2028
2014
Q3
$10.5M Hold
240,429
﹤0.01% 1994
2014
Q2
$14.4M Hold
240,429
﹤0.01% 1937
2014
Q1
$18.9M Hold
240,429
﹤0.01% 1782
2013
Q4
$14.6M Hold
240,429
﹤0.01% 1836
2013
Q3
$15.8M Buy
240,429
+66,666
+38% +$5.39M ﹤0.01% 1780
2013
Q2
$16M Buy
+173,763
New +$14.4M ﹤0.01% 1745

Other funds holding FCSC

Fidelity Investments's FCSC Position: Q4 2017 in Review

Fidelity Investments sold out of Fibrocell Science Inc. (FCSC) in Q4 2017, closing a stake of 117,483 shares — an estimated $1.8M sold.

Fidelity Investments first reported a position in FCSC in Q2 2013 and held it in 18 quarters. The position peaked at $19M in Q2 2015. 32 funds tracked by Wall St. Rank hold FCSC as of Q4 2017.

  • Fidelity Investments reported no remaining Fibrocell Science Inc. position as of Q4 2017 after selling out during the quarter.
  • Fidelity Investments sold 117,483 Fibrocell Science Inc. shares in Q4 2017, an estimated $1.8M.
  • Fidelity Investments first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 18 quarters.
  • Fidelity Investments's Fibrocell Science Inc. position peaked at $19M in Q2 2015.
  • 32 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2017.

Based on Fidelity Investments's 13F filing for Q4 2017, filed 12 Feb 2018.